Heart transplantation is recommended for patients with advanced heart failure refractory to medical and device therapy, and who do not have absolute contraindications. When patients become eligible for heart transplantation, they undergo comprehensive evaluation and preparation to optimize their posttransplantation outcomes. This review provides an overview of the processes that are employed to enable the candidates to be transplant-ready when donor hearts are available.
Keywords: Anti-HLA antibodies; Antibody-mediate rejection; Ferric carboxymaltose; Iron deficiency anemia; Prehabilitation.
Copyright © 2022 Elsevier Inc. All rights reserved.